To see the role of Baladi Churna through Oral route and Dhanwantara Taila through Anal route in the treatment of Infertility due to unruptured egg.

Role of Baladi Churna and Dhanwantara taila in management of Anovulatory factor of Infertility-A randomized,open label,comparative clinical trial

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020153

Enrollment

Registered

2019-07-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

Intervention1: Matra Basti: Matra Basti with Dhanwantara taila(60 ml) for 7 days after stoppage of menstruation for 3 cycles. Intervention2: Oral Baladi Churna: Baladi Churna 3gm twice in a day for 15

Eligibility

Inclusion criteria

Inclusion criteria: 1.Married female patients of reproductive age group having active married life (minimum 1 year)who had complaint of unable to conceive since 1 year 2.Primary and Secondary both types of infertile patients having anovulatory cycle or with unruptured ovarian follicle will be included in the study.

Exclusion criteria

Exclusion criteria: 1.Patient having age less than 19 years and more than 40 years. 2.Patients suffering from disorders of reproductive tract like tuberculosis,carcinoma,congenital deformities. 3.Patients suffering from sexually transmitted disease like VDRL,HIV will be excluded.

Design outcomes

Primary

Measure	Time frame
Ovulation Timepoint: 150 days	—

Secondary

Measure	Time frame
Improvement in size of follicleTimepoint: 150	—

Countries

India

Contacts

Public ContactDr Nidhi Bajpai

All India Institute Of Ayurveda,New Delhi

kd44ayu@yahoo.co.in8920900968

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026